Catheterization and Cardiovascular Interventions

Catheterization and Cardiovascular Interventions is the peer-reviewed journal of the Society for Cardiovascular Angiography and Interventions, published by Wiley and descended from a diagnostic catheterization title launched in 1975. It reports invasive and interventional practice across coronary, structural, peripheral and congenital cardiovascular disease, and its 2025 Journal Impact Factor is 1.9.《导管插入与心血管介入》是美国心血管造影与介入协会的同行评审期刊，由 Wiley 出版，前身是 1975 年创刊的心导管诊断刊物。刊物覆盖冠状动脉、结构性心脏病、外周血管与先天性心脏病的侵入性诊疗，2025 年期刊影响因子为 1.9。

Scope

• Coronary intervention forms the journal's core, spanning drug-eluting stents, drug-coated balloons, calcium modification by atherectomy or intravascular lithotripsy, bifurcation and left main techniques, and the antithrombotic regimens that accompany them.冠状动脉介入是刊物的核心内容，涵盖药物洗脱支架、药物涂层球囊、旋磨与血管内碎石等钙化修饰手段，以及分叉与左主干技术和配套的抗栓方案。
• Chronic total occlusion work receives sustained attention, from wire escalation and dissection-reentry strategies to retrograde approaches, with procedural success and long-term patency reported alongside the technical detail.慢性完全闭塞病变的介入同样受到持续关注，从导丝升级与夹层再入策略到逆向途径，技术细节与手术成功率及远期通畅率一并报告。
• Structural heart disease is covered through transcatheter aortic and mitral valve procedures, leaflet repair, left atrial appendage occlusion, and closure of atrial septal defects or patent foramen ovale.结构性心脏病方面覆盖经导管主动脉瓣与二尖瓣治疗，也涉及瓣叶修复与左心耳封堵，还包括房间隔缺损和卵圆孔未闭的封堵。
• Congenital cardiac intervention appears in both paediatric and adult practice, including stenting of conduits, treatment of coarctation, and device closure of septal and ductal defects.先天性心脏病介入兼顾儿童与成人患者，涉及管道支架植入、主动脉缩窄处理，以及间隔缺损和动脉导管未闭的封堵。
• Peripheral vascular papers address iliac and femoropopliteal disease, below-the-knee arteries, carotid and renal intervention, and venous reconstruction, usually with an eye on the operator's own practice.外周血管论文涉及髂动脉与股腘动脉病变，也讨论膝下动脉、颈动脉和肾动脉介入以及静脉重建，落点常在介入医师自己的操作实践。
• Catheter-laboratory craft is treated as a subject in its own right: radial and femoral access, closure devices, guide extension, support techniques, and the ergonomics of complex cases.导管室操作本身也是独立选题，包括桡动脉与股动脉入路、封堵器、导引导管延伸与支撑技术，以及复杂病例的操作体验。
• Intravascular imaging and physiology sit at the centre of the diagnostic interest, with ultrasound and optical coherence tomography represented as often as fractional flow reserve, instantaneous wave-free ratio and computed tomography based planning.血管内影像与生理学评估居于诊断类内容的中心，血管内超声和光学相干断层成像出现得与血流储备分数同样频繁，瞬时无波形比值与 CT 规划类研究也在其中。
• Complications are examined without euphemism, covering perforation, no-reflow, stent thrombosis, contrast-associated kidney injury, and radiation exposure among operators and patients.并发症讨论不回避细节，穿孔与无复流、支架内血栓和对比剂相关肾损伤都有专门分析，术者与患者的辐射暴露同样在列。
• Registry analyses and trial substudies are staples, drawing on national cardiovascular registries and multicentre cohorts to describe how interventions perform outside the controlled setting.注册数据分析与试验亚组研究是常态内容，取材于全国性心血管注册登记与多中心队列，用来描述介入治疗在受控试验之外的实际表现。
• Preliminary Reports give first-in-human and early feasibility device work a home, a format the journal has kept since its diagnostic years.初步报告栏目为首次人体研究与器械早期可行性探索提供出口，这一体例从旧刊的诊断时代一直延续下来。
• Work in Progress articles report unfinished programmes and interim experience, allowing readers to follow device development before final results are assembled.进行中的工作报告刊载尚未收尾的研究计划与阶段性经验，读者可以借此跟踪器械研发在最终结果成形之前的进展。
• Comprehensive reviews and society documents summarise evidence for common decisions, including consensus statements prepared together with the Society for Cardiovascular Angiography and Interventions.综合综述与学会文件为常见临床决策梳理证据，其中包括与美国心血管造影与介入协会共同准备的共识声明。
• Letters to the editor keep the back pages busy, more than twenty of them since the start of 2025, many disputing how a trial or a head-to-head device comparison was read.读者来信让尾栏保持热闹，2025 年初以来已逾二十篇，其中不少在争论某项试验或某组器械头对头比较该如何解读。
• Training, case selection and laboratory quality round out the scope, since the intended reader works inside the catheterization laboratory rather than at a distance from it.培训、病例选择与导管室质量构成范围的收束部分，因为刊物的目标读者正是在导管室内工作的医师，而非远观的旁观者。

History

• The title began in 1975 as Catheterization and Cardiovascular Diagnosis, issued in New York by Alan R. Liss, and its first volume carried the diagnostic emphasis of that decade.刊物 1975 年以《心导管术与心血管诊断》之名创刊，由纽约的 Alan R. Liss 出版，第 1 卷的内容仍带着那个十年的诊断偏向。
• Those early years were defined by angiography and haemodynamic measurement, then reshaped by balloon angioplasty, which Andreas Gruentzig first performed in 1977 and which widened what a catheterization journal had to cover.早期内容以造影与血流动力学测量为主，随后被球囊血管成形改写，Andreas Gruentzig 于 1977 年完成首例操作，心导管刊物的报道范围由此扩大。
• Volume 45 closed in December 1998 with its fourth number, and the next issue appeared in January 1999 under the new title, so the volume count continued without a break at 46.第 45 卷在 1998 年 12 月以第 4 期收尾，紧接着的 1999 年 1 月号改用新刊名，卷号在第 46 卷上无缝接续。
• The renaming tracked a shift in the field, as catheter laboratories moved from measuring disease to treating it, and the word interventions entered the masthead.更名对应的是学科重心的移动，导管室从测量病变转向处理病变，介入一词由此进入刊名。
• From 1999 the journal has been the official organ of the Society for Cardiac Angiography and Interventions, the body that later adopted the name Society for Cardiovascular Angiography and Interventions.自 1999 年起，刊物成为美国心脏造影与介入学会的会刊，该学会后来改称美国心血管造影与介入协会（Society for Cardiovascular Angiography and Interventions）。
• Wiley-Liss stood on the imprint when the new title launched, after the original publisher had been absorbed into John Wiley and Sons, and Wiley now carries the title under its own name.新刊名启用时刊头署的是 Wiley-Liss，此前原出版方已并入 John Wiley and Sons，如今刊物直接署 Wiley 之名。
• Issue counts moved with the specialty: twelve numbers a year in three volumes of four until 2006, then fourteen regular numbers in two volumes of seven, a pattern set in 2007 and still kept.期数随专科扩张而调整，2006 年以前每年 12 期、分作三卷各四期，2007 年起改为每年两卷各七期共 14 期正刊，这一格局沿用至今。
• The present rhythm delivers an issue roughly every three to four weeks, with supplements printed alongside the numbered sequence rather than folded into it.按现在的节奏，读者大约每三到四周收到一期，增刊与编号正刊并行出版，并不并入正刊编号。
• Access has stayed largely subscription based with a hybrid option, and gold open access accounts for about 28 percent of recent content.访问模式长期以订阅为主，同时提供混合开放获取选项，近年金色开放获取论文约占 28%。
• The Journal Impact Factor has drifted down from 2.692 in 2021 to 1.9 in 2025, against a five-year figure of 2.0 and total citations above ten thousand.期刊影响因子从 2021 年的 2.692 回落到 2025 年的 1.9，五年影响因子为 2.0，总被引超过一万次。
• Output is heavy for a subspecialty journal, close to 600 articles a year, which keeps review queues and production schedules under constant pressure.对一本亚专科刊物而言，年发文接近 600 篇，这一规模使审稿队列与出版排期长期处于紧张状态。
• Digital object identifiers sit under Wiley's 10.1002 prefix with a suffix of ccd and a number, while papers from the first online years still carry the long SICI strings in which ccd appears only as the article code.数字对象标识符统一在 Wiley 的 10.1002 前缀之下，后缀取本刊缩写加流水号，最早一批线上论文仍是当年的长串 SICI 编码，刊名缩写在其中只作为文章代码出现。
• In 2022 the society launched a separate open-access outlet, the Journal of the Society for Cardiovascular Angiography and Interventions, leaving this title to carry the established subscription record.2022 年学会另行创办开放获取期刊 Journal of the Society for Cardiovascular Angiography and Interventions，本刊则继续承载学会既有的订阅型刊物传统。
• Citation totals near eleven thousand place the journal mid-field among cardiac and cardiovascular systems titles, where it sits in the third quartile of the 2025 ranking.接近一万一千次的总被引使刊物在心脏与心血管系统类期刊中处于中游，2025 年排名落在第三四分位。

Editors

• Steven R. Bailey signs the editor-in-chief letters that have appeared in recent volumes, including the one published in December 2024.近年各卷的主编来信由 Steven R. Bailey 署名，2024 年 12 月刊登的那封也出自他手。
• The addresses printed under his letters pair the Malcolm Feist Chair of Interventional Cardiology at UT Health San Antonio with a professorship at LSU Health Shreveport.他署名下方的两条地址分别是得克萨斯大学圣安东尼奥健康科学中心的 Malcolm Feist 介入心脏病学讲席与路易斯安那州立大学健康科学中心什里夫波特分校的教授职位。
• Earlier leadership is documented in the journal's own pages, which recorded the reappointment of Christopher J. White to a second term as editor-in-chief in 2005.更早的编辑部人事记录在刊物自身的版面上，2005 年的一则消息记载 Christopher J. White 获任第二届主编。^[1]
• A group of deputy and associate editors handles the daily reading of manuscripts, dividing labour between coronary, structural, peripheral and congenital submissions.副主编与协理编辑团队承担日常稿件阅读，按冠状动脉、结构性心脏病、外周血管与先天性心脏病分线处理。
• The board and reviewer pool mirror the journal's authorship, which the affiliation lines of 2025 and 2026 show to be led by United States centres, with China, Japan and Italy close behind and steady British, Spanish and German contributions.编委与审稿人构成同作者分布相呼应，2025 年与 2026 年的署名地址显示美国机构居首，中国、日本与意大利紧随其后，英国、西班牙与德国的投稿也稳定可见。
• Manuscripts are screened by the editorial office before review, and submissions outside the laboratory-facing remit are returned quickly instead of being sent out.稿件先经编辑部初筛再进入评审，偏离导管室实务定位的投稿通常直接退回，而不送外审。
• Peer review relies on external referees with procedural expertise, which is what separates the journal from general cardiology titles.评审依赖具备操作经验的外部审稿人，这也是刊物区别于一般心脏病学期刊的地方。
• Accepted work goes online first with a DOI, and Crossref still holds a run of recent records with no volume or issue attached, so a paper is often read long before it is assigned to a number.录用的论文先带 DOI 上线，Crossref 里仍有一批近期记录尚未挂上卷期，读者常常在论文编入某一期之前就已读到。
• Teaching material takes up a good share of what editors accept, with close to a hundred reviews and more than seventy case reports among the pieces posted since the start of 2025.编辑接受的稿件里教学性内容占去不少版面，2025 年初以来上线的论文中，综述近百篇，病例报告七十余篇。
• Letters disputing or extending a paper are printed, and the original authors are given a reply, the two often appearing in the same volume.对已发表研究提出异议或补充的来信照登，原作者亦有答复的版面，两者常在同一卷内出现。
• Supplements run outside the numbered sequence, one to three in most years, and carry material that the regular numbers leave out.增刊排在编号正刊之外，多数年份有一到三册，收录的是常规期次容纳不下的内容。
• Submission runs through the publisher's online system, and the author guidelines set word limits, structured abstracts and the imaging documentation expected for case reports.投稿经出版方的在线系统完成，作者指南对字数上限、结构式摘要以及病例报告所需的影像附件都有规定。